News
11h
Axios on MSNVinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...
FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...
Marty Makary named Vinay Prasad as the next director of the Center for Biologics and Research, Endpoints News has learned.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results